CLARENDON MEDICAL CENTRE
CLARENDON STREET, HYDE
HF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2010 | 12 | 17 | 70.6% | |
| HF 4 | 2011 | 13 | 18 | 72.2% | |
| HF 4 | 2012 | 11 | 18 | 61.1% | |
| HF 4 | 2013 | 7 | 11 | 63.6% | |
| HF004 | 2014 | 7 | 9 | 77.8% | |
| HF004 | 2015 | 36 | 41 | 87.8% | |
| HF004 | 2016 | 30 | 36 | 83.3% | |
| HF004 | 2017 | 40 | 44 | 90.9% | |
| HF004 | 2018 | 48 | 54 | 88.9% | |
| HF004 | 2019 | 43 | 48 | 89.6% | |
| HF004 | 2020 | 41 | 46 | 89.1% | |
| HF006 | 2021 | 56 | 63 | 88.9% | |
| HF006 | 2022 | 53 | 57 | 93.0% | |
| HF006 | 2023 | 49 | 52 | 94.2% |
